Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Chronic venous disease

Chronic venous disease encompasses persistent structural or functional changes in the venous system that produce symptoms or signs warranting clinical assessment. In the lower extremities, the spectrum ranges from early manifestations, such as telangiectasias, reticular veins and varicose veins, to edema, skin changes and ulceration. It is not a single anatomical lesion: valvular reflux, outflow obstruction and an inefficient muscle pump may contribute in different combinations, producing conditions that require different strategies.

The term chronic venous insufficiency is generally reserved for forms in which hemodynamic abnormalities are accompanied by edema and more substantial tissue consequences, corresponding mainly to clinical classes C3–C6. A small varicose vein and a leg with lipodermatosclerosis do not therefore represent the same degree of disease. Conversely, the number of visible veins does not in itself measure functional impairment: significant deep venous obstruction may occur without prominent varices, whereas some superficial dilations cause few symptoms.

Prevalence increases with age, family history, obesity and previous venous events, but epidemiological estimates vary according to the population and definition used. Including all telangiectasias yields very different rates from counting only forms with skin changes. Longitudinal studies, including the Edinburgh Vein Study, document the possibility of progression, not an inevitable course toward ulceration. Clinical assessment should identify the predominant mechanism, measure the effect on everyday life and determine when intervention may offer a tangible benefit.

Organization of the venous circulation and major forms of disease

The venous system of the lower extremities consists of superficial and deep veins, connected by perforating veins. The great and small saphenous veins run in their respective fascial compartments and collect blood from numerous tributaries; deep veins accompany the arteries and receive blood from the muscles. These connections do not constitute independent tubes but a network in which a change affecting one segment can alter the load on others. An accurate description must therefore distinguish saphenous trunks, tributaries, perforators and deep outflow pathways, rather than summing up the entire disease under the generic term “varicose veins”.

Venous valves limit retrograde flow as pressure changes with posture and muscle contraction. Their competence depends on the integrity of the leaflets and their relationship to the vessel wall: a dilated vein may prevent proper leaflet coaptation even without primary destruction of the cusps. Changes in the extracellular matrix and wall tone may therefore precede or accompany reflux. Primary disease should not be understood solely as an initially normal valve that suddenly fails.

In primary forms , individual predisposition, wall remodeling and valve changes contribute without an obvious preceding causative event. Pregnancies, excess body weight and prolonged immobility while standing may influence the onset or progression of symptoms. However, these associations do not allow every symptom to be attributed to a single habit. Biological susceptibility and the mechanical environment interact over time; reflux may be segmental or involve more extensive venous pathways.

Secondary forms result from identifiable injury, frequently deep vein thrombosis. Thrombus organization, irregular recanalization and valve damage may leave both obstruction and reflux. Post-thrombotic syndrome is the chronic clinical manifestation of this process, not merely the ultrasound finding of residual material. Other causes include external compression and sequelae of trauma or surgery. Rare congenital forms require specific assessment because an abnormal venous network may provide essential drainage pathways.

Iliocaval outflow connects the limbs to the central circulation. Proximal obstruction can cause marked swelling, venous claudication or pelvic collateral veins, but incidental anatomical compression does not establish symptomatic disease. In May–Thurner syndrome , clinical significance depends on agreement between the lesion and impaired drainage. This principle protects against overinterpretation of imaging: identifying a narrowing is only one part of the evaluation, which must also explain symptoms and consider alternatives.

A focal dilation requires interpretation distinct from diffuse varicose tortuosity. A venous aneurysm may affect superficial or deep sites and have different implications depending on anatomy and the presence of thrombus. It is not simply a more advanced stage of common saphenous disease. This distinction broadens venous assessment without confusing different entities: the risk and treatment of a localized lesion cannot be inferred solely from the presence of limb symptoms associated with stasis.

From altered flow to microcirculatory injury

When standing, hydrostatic pressure increases in distal regions. While walking, contraction of the calf muscles propels blood toward the heart and the valves limit reflux, allowing distal venous pressure to fall. Ankle function is part of this mechanism: joint stiffness, pain and muscle weakness reduce pump efficiency. A relatively intact valvular system may therefore drain poorly if the person walks little or does not move the joint adequately.

Reflux accelerates retrograde refilling of the compartment emptied by contraction, whereas obstruction impedes blood ejection. When these mechanisms exceed compensatory capacity, pressure remains excessively high during activity: ambulatory venous hypertension develops. This term refers to the failure to lower venous pressure adequately through movement, not simply to an elevated value measured while standing. The distinction explains why anatomical severity, symptoms and pump function must be assessed together.

The increased pressure is transmitted to the microcirculation, promoting capillary dilation and greater filtration of fluid and proteins. Lymphatic drainage may initially compensate for the excess, but persistent overload exceeds its capacity. Chronic edema may thus acquire a lymphatic component, sometimes termed phlebolymphedema. At this stage, correcting one pathological vein may not immediately resolve all swelling because the tissues and fluid-removal system have undergone changes of their own.

The inflammatory response involves endothelial cells, leukocytes and mediators that alter permeability and the extracellular matrix. Stasis and wall stresses change the mechanical signals perceived by cells; inflammatory activation in turn contributes to remodeling. Describing this simply as “stagnant” blood is insufficient: it is an interaction among pressure, flow and tissue biology. At advanced stages, fibrosis and small-vessel abnormalities may make the consequences of longstanding hemodynamic disturbance less reversible.

Extravasation of erythrocytes and iron metabolism contribute to hemosiderin pigmentation. Inflammation and subcutaneous remodeling may cause lipodermatosclerosis, while the skin barrier becomes more vulnerable to irritation and sensitization. Ulceration arises from a complex impairment of local homeostasis, often facilitated by minimal trauma. A single theory of “lack of oxygen” does not adequately explain it, because inflammatory, microvascular, interstitial and repair abnormalities contribute to varying degrees.

The relationship with physical activity is bidirectional. Movement supports venous return, but pain, edema and stiffness may restrict mobility and maintain pump dysfunction. Obesity can add abdominal pressure, mechanical load and difficulty using compression. This is why care is not limited to the vessel: rehabilitation, mobility, weight management and skin protection affect the functioning of the entire system. Anatomical correction and functional recovery are complementary components of treatment.

Clinical manifestations and description of severity

Symptoms include heaviness, tightness, pain and itching, often worsening after prolonged standing and improving with elevation. Evening swelling and reduced tolerance for activities may also be reported. These symptoms are nevertheless nonspecific: cramps, burning and leg pain may also arise from neurological, joint or muscular conditions. The presence of varicose veins does not justify automatically attributing every symptom to them, particularly when the location, time course and triggers are inconsistent with a venous mechanism.

The CEAP classification organizes the description according to clinical, etiological, anatomical and pathophysiological findings. In the clinical component, C0 means no visible or palpable signs, C1 indicates telangiectasias or reticular veins and C2 varicose veins; C3 denotes edema. The C4 classes include skin and subcutaneous changes, C5 a healed ulcer and C6 an active ulcer. Updated subdivisions allow more precise description of findings such as corona phlebectatica and recurrent disease. The classification records the clinical picture but does not itself establish that every skin lesion is venous in origin.

Venous edema often affects the ankle and leg and may decrease overnight, especially in the early stages. As it becomes chronic, it may be more persistent and accompanied by induration. Comparing the limbs, assessing foot involvement and looking for systemic signs help distinguish venous, lymphatic and general causes. The same patient may have more than one mechanism: heart failure, medications and venous disease are not mutually exclusive diagnoses, and their relative contribution should be estimated.

Trophic changes are especially significant because they indicate lasting tissue consequences. Eczema, pigmentation, atrophie blanche and lipodermatosclerosis guide the assessment but require dermatological interpretation when atypical. A venous ulcer is often located in the supramalleolar region and is associated with pain, exudate and recurrence risk. However, a wound cannot be classified as venous solely because of its location: ischemia, vasculitis, malignancy and other causes may produce similar lesions or coexist with stasis.

The Venous Clinical Severity Score allows symptoms and signs to be followed over time, whereas quality-of-life measures capture limitations that anatomical classification misses. CEAP is mainly descriptive; repeated clinical scoring is more suitable for documenting certain changes after treatment. None of these tools should be used alone to authorize a procedure. Meaningful improvement for the patient may mean walking longer or being able to wear a shoe, even without the disappearance of every visible sign.

Some findings require departure from routine chronic-disease management. Sudden swelling of one limb may indicate new DVT; fever, severe pain and rapidly spreading redness suggest infection or another complication. Bleeding from a superficial vein requires local compression and elevation, with urgent assessment according to its extent and the patient’s overall condition. Recognizing these changes prevents familiarity with a longstanding condition from leading to underestimation of an acute event that is clinically distinct from usual evening heaviness.

Diagnostic pathway and second-line investigations

The medical history should clarify onset, changes over the course of the day, the relationship to posture and activity, previous thromboses and treatments. Pregnancies, family history, mobility limitations, weight, medications and conditions that can cause edema are relevant. A documented history of DVT helps interpret deep venous findings, but the patient may also have primary reflux. Individual goals, such as standing at work, walking or wound care, provide essential information for deciding which investigations and interventions can offer tangible benefit.

Examination while standing, when feasible, makes the distribution of varicose veins and the effects of gravity more apparent. Both limbs, skin, joints, ankle strength and mobility, and pulses should be assessed. Swelling must be described by location and consistency. A localized mass or abdominal collateral veins require particular attention. The examination should establish the clinical question for ultrasound: merely requesting a generic “venous Doppler” may yield an incomplete answer to suspected reflux, obstruction or thrombosis.

Color duplex ultrasonography is the main instrumental test. It should assess patency, valve competence and relevant connections, documenting abnormal segments under appropriate conditions of posture and flow provocation. A useful map distinguishes the origin and distribution of reflux, the state of deep veins and the possible contribution of perforators. Saphenous vein diameter alone is insufficient to select treatment. Documented reflux must also be correlated with clinical findings, because mild or localized abnormalities may not explain diffuse edema.

Arterial assessment is particularly important before substantial compression in patients with ulcers, diminished pulses or atherosclerotic risk factors. The ankle–brachial index is useful but may be falsely elevated in noncompressible arteries; toe pressures and other investigations can then provide further information. Coexisting arterial and venous disease changes compression intensity and monitoring. A mixed-etiology wound requires a different strategy from a venous ulcer with preserved perfusion.

When there is evidence of proximal obstruction, abdominal-pelvic ultrasonography, CT or MR venography may characterize the iliac veins and vena cava. Invasive examinations, including intravascular ultrasonography, are mainly reserved for questions that may lead to a procedure. They are not obligatory second-line tests for every varicose vein. Plethysmography and dedicated hemodynamic assessments may help in selected cases when anatomy and symptoms disagree, while systemic investigations should be based on clinical suspicion rather than indiscriminate standard panels.

The final diagnosis should integrate the cause, compartment involved, reflux or obstruction and clinical severity. Assessment of chronic venous insufficiency must then link this description to function and tissue injury. An anatomical report cannot replace that synthesis. If examinations show a mild abnormality despite substantial disability, additional explanations should be sought rather than overstating the significance of the finding to fit a previously assumed diagnosis.

Conservative treatment and symptom control

Care begins by defining measurable goals: reducing pain and edema, improving mobility, protecting the skin or promoting wound healing. A mild asymptomatic finding does not require the same pathway as a recurrent ulcer. Education and shared decision-making are especially important because many measures must be maintained in everyday life. The theoretical efficacy of a device or prescription has little value if the patient cannot use it or if it conflicts with unaddressed physical limitations.

Regular movement and calf exercises support the muscle pump. The program must be compatible with balance, cardiopulmonary status, pain and joint condition. Changing positions during work and elevating the limbs during periods of congestion may relieve symptoms. Weight management has a functional rationale as well as a general one: it facilitates walking, skin care and putting on stockings. These measures do not reconstruct a damaged valve, but improve the functioning of the system in which the lesion occurs.

Compression reduces venous distension and interstitial fluid accumulation and may improve pump efficiency. Stockings, bandages and adjustable devices differ in pressure, stiffness and ease of use. Selection depends on severity, arterial perfusion, limb shape and ability to apply the device. Prescribing a “class” without knowing the reference standard is insufficient because commercial classifications may differ. Correct measurements, skin checks and adjustment after edema decreases are part of treatment.

Venoactive medications may provide additional relief of some symptoms in selected patients. Effects and evidence quality vary by molecule and outcome; systematic reviews do not support the idea that all products are equivalent or prevent progression. Response should be reassessed against tolerability and practical benefit. Conversely, anticoagulation is not a treatment for common chronic venous stasis in the absence of a thromboembolic indication or another specific reason.

Protection of the skin barrier includes appropriate cleansing, emollients and treatment of eczema when present. Multiple topical preparations and prolonged use of sensitizing substances may aggravate dermatitis. Antibiotics are reserved for clinical infection, not pigmentation alone or simple wound colonization. In ulcerative disease, dressings are selected according to wound characteristics, but control of venous hypertension remains critical: an advanced dressing cannot compensate for outflow that has not been assessed.

Monitoring the response allows problems with adherence to be corrected and incomplete diagnoses to be identified. A stocking that is too difficult to put on can be replaced with a more manageable option; edema that does not change requires reassessment of the lymphatic component, systemic conditions and adequacy of compression. Conservative management can be definitive for many patients and complementary to a procedure for others. It should not be presented as an identical mandatory ritual for everyone before an appropriate intervention can be considered.

Anatomical treatments and procedure selection

When clinically relevant superficial reflux causes symptoms or skin injury, correcting it may improve the condition. Options include thermal ablation, nonthermal techniques, sclerotherapy and surgery, selected according to anatomy and context. The target must be defined by ultrasonography: closing a visible vein without identifying the source of reflux may leave the main mechanism intact. Likewise, treating a saphenous vein merely because it is large does not guarantee relief of symptoms attributed to venous stasis.

The presence of deep venous reflux does not always rule out benefit from superficial treatment, but requires a comprehensive hemodynamic interpretation. In genuine deep venous obstruction, some superficial veins may contribute to collateral drainage and must be identified before they are removed. Distinguishing reflux from obstruction is therefore operational, not merely descriptive. In mixed conditions, the sequence and targets of treatment are chosen according to the affected segments and predominant clinical problem.

For symptomatic iliocaval obstruction, endovascular reconstruction may be indicated in selected patients after assessment establishes a plausible relationship between the lesion and disability. The evidence and prognosis differ between nonthrombotic lesions and post-thrombotic disease. Recent results of the C-TRACT trial concern a population with significant post-thrombotic syndrome and iliac obstruction and do not justify preventive stenting of incidental compression. Every stent also entails surveillance and the possibility of complications or repeat interventions.

Incompetent perforating veins may contribute to local hypertension, especially in advanced cases, but should not be treated indiscriminately whenever they are visible on ultrasound. Their significance depends on their relationship to an ulcer, superficial reflux and the deep venous system. Correcting a primary source may also change the behavior of connections. Deep venous valve procedures are reserved for experienced centers and selected patients because of anatomical complexity and limited evidence for many reconstructions.

In a treatable ulcer associated with superficial reflux, evidence from the EVRA trial supports a pathway combining compression with early ablation in patients with suitable characteristics. It is not always necessary to wait for complete wound closure before considering hemodynamic correction. This finding does not automatically extend to ischemic or atypical ulcers or ulcers caused by complex obstruction. The wound must be assessed and treatment selected according to the mechanism actually present, while continuing local care and management of comorbidities.

Outcome assessment includes symptom relief, healing, quality of life and duration of benefit, as well as technical success. A successfully closed vein or a patent stent is an important anatomical outcome but does not capture the full meaning of treatment. Recurrence, nerve injury, procedure-related thrombosis, bleeding and skin problems must be considered. The best choice is the one offering benefit proportionate to risk in the specific context, not the one eliminating the largest number of visible abnormalities.

Natural history, complications and long-term care

Progression varies. Some forms remain stable for years, whereas others develop edema and skin changes, particularly with persistent risk factors and substantial hemodynamic injury. Family history, obesity and previous thrombosis help define the context but do not predict the individual course with certainty. Initial classification should therefore be followed by clinical reassessment when signs or symptoms change. Not all patients need serial examinations at the same frequency.

Recurrence after treatment may result from progression in other segments, recanalization, new connections or persistence of an untreated source. It does not necessarily mean that the earlier procedure was inappropriate. New venous mapping should distinguish these mechanisms before further interventions are proposed. A return of heaviness without obvious varicose veins may also reflect nonvenous conditions; a history of successful treatment therefore does not replace a new, comprehensive clinical assessment.

Complications include superficial thrombosis and bleeding from vulnerable veins, as well as eczema, skin infections and ulceration. Superficial thrombosis requires assessment of its extent and relationship to the deep system; it is not merely a local inflammatory episode. Bleeding may be significant in frail or anticoagulated patients. Prevention of further bleeding also requires treatment of the responsible vein and underlying disease, not just healing of the small skin lesion through which blood escaped.

The chronic nature of the wound causes pain, sleep disturbances, mobility difficulties and a substantial care burden. The risk of reopening persists after healing, particularly if venous hypertension and difficulties with compression remain. Skin closure is therefore an intermediate goal that requires a maintenance strategy. Assessment should also include nutrition, independence and access to support, because continuity of care depends on practical conditions that directly influence outcomes.

Coexisting systemic disease requires coordinated care. A patient with heart failure, peripheral arterial disease and venous stasis may need adapted compression and more frequent monitoring. Diuretics correct systemic fluid overload when present, but they do not repair reflux or obstruction and should not become the automatic treatment for every swollen ankle. Separating etiological contributions helps avoid both insufficient treatment and unnecessary long-term prescriptions simply because the symptom is chronic.

Functional prognosis improves when diagnosis, correction of the underlying mechanism and everyday support are integrated. Outcomes may include less need for dressings, better tolerance of standing or fewer episodes of swelling. Chronic venous disease therefore requires a longitudinal perspective capable of distinguishing mild signs, hemodynamic insufficiency and specific complications. The precision of this distinction allows proportionate care to be offered, keeping limb function and the patient’s needs central.

Bibliography
  1. De Maeseneer MG et al. Editor's Choice – European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. European Journal of Vascular and Endovascular Surgery. 2022;63(2):184–267.
  2. Gloviczki P et al. The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2024;12(1):101670.
  3. Attaran RR et al. 2025 SCAI Clinical Practice Guidelines for the Management of Chronic Venous Disease: This statement was endorsed by the Society for Vascular Medicine (SVM). Journal of the Society for Cardiovascular Angiography & Interventions. 2025;4(8):103729.
  4. Lurie F et al. The 2020 update of the CEAP classification system and reporting standards. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2020;8(3):342–352.
  5. Vasquez MA et al. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. Journal of Vascular Surgery. 2010;52(5):1387–1396.
  6. Eberhardt RT et al. Chronic venous insufficiency. Circulation. 2014;130(4):333–346.
  7. Bergan JJ et al. Chronic Venous Disease. The New England Journal of Medicine. 2006;355(5):488–498.
  8. Ortega MA et al. Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management. Journal of Clinical Medicine. 2021;10(15):3239.
  9. Lee AJ et al. Progression of varicose veins and chronic venous insufficiency in the general population in the Edinburgh Vein Study. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2015;3(1):18–26.
  10. Rabe E et al. Risks and contraindications of medical compression treatment – A critical reappraisal. An international consensus statement. Phlebology. 2020;35(7):447–460.
  11. Martinez-Zapata MJ et al. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews. 2020;11:CD003229.
  12. Kahn SR. The post-thrombotic syndrome. Hematology, American Society of Hematology Education Program. 2016;2016(1):413–418.
  13. Gohel MS et al. A Randomized Trial of Early Endovenous Ablation in Venous Ulceration. The New England Journal of Medicine. 2018;378(22):2105–2114.
  14. Desai KR et al. Consensus Statement on the Management of Nonthrombotic Iliac Vein Lesions From the VIVA Foundation, the American Venous Forum, and the American Vein and Lymphatic Society. Circulation: Cardiovascular Interventions. 2024;17(8):e014160.
  15. Vedantham S et al. Endovascular Therapy for Post-Thrombotic Syndrome — A Randomized Trial. The New England Journal of Medicine. 2026;394(23):2293–2304.
  16. Kakkos SK et al. Editor’s Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. European Journal of Vascular and Endovascular Surgery. 2021;61(1):9–82.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.